Progress in the underlying science of prostate cancer management

Patients (and others) who are interested in an overview of the possible future of development of new agents for the treatment of advanced forms of prostate cancer may want to invest a few bucks in the full text of this recent article by Miyahira et al., which summarizes presentations and discussions at the 2014 meeting of the Coffey–Holden Prostate Cancer Academy (held in La Jolla in June 2014 and sponsored by the Prostate Cancer Foundation).

The meeting focused primarily on scientific factors affecting the development and evolution of immunotherapies in the management of prostate cancer, but be warned: the content is liable to very technical and any short-term relevance to the management of prostate cancer is limited.

For those who don’t have a few bucks to spare, the Prostate Cancer Foundation also offers (at no cost via its web site) a series of annual reports on the “State of the Science” of prostate cancer and other associated topics. The “State of the Science” report for 2014 is still to be published, so the latest available is the 2013 report.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: